StockData
Absci Corp logo

Absci Corp (ABSI) stock

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$7.58+0.11 (+1.40%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

Earnings

Absci's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 23, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$300.00K
-25.0% on a year earlier
EPS, Q3 FY2026
-$0.19
-$0.20 a year earlier
Latest guidance
Lowered
Nov 12, 2024 · 1 item

Quarterly results

Revenue and earnings per share from each of Absci's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open$300.00K-25.0%-$0.19Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026after the close$300.00K-50.0%–Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$200.00K-83.3%-$0.19Release
Q4 FY2025ended Dec 31, 2025Mar 24, 2026after the close$700.00K0.0%-$0.20Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025after the close$400.00K-76.5%-$0.20Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025after the close$600.00K-53.8%-$0.24Release
Q1 FY2025ended Mar 31, 2025May 13, 2025after the close$1.20M+33.3%-$0.21Release
Q4 FY2024ended Dec 31, 2024Mar 18, 2025after the close$700.00K+133.3%–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$1.70M+142.9%–Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024after the close$1.30M-61.8%-$0.22Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open$900.00K-30.8%-$0.22Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Absci guided for has been reported

Guidance history

Every forecast Absci put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 12, 2024gross use of cash, cash equivalents, and short-term investmentsFY2024$75.00MLowered
Aug 14, 2024gross use of cash, cash equivalents, and short-term investmentsFY2024$80.00MReaffirmed
May 14, 2024gross use of cash, cash equivalents, and short-term investmentsFY2024$80.00MReaffirmed
Mar 21, 2024gross use of cash, cash equivalents, and short-term investmentsFY2024$80.00MNew
Nov 14, 2023gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receiptsFY2023$80.00MLowered
Aug 14, 2023gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receiptsFY2023$90.00MReaffirmed
May 15, 2023gross use of cash, cash equivalents, and short-term investmentsFY2023$90.00MReaffirmed
Mar 30, 2023gross use of cash, cash equivalents, and short-term investments, exclusive of partnered program and equipment financing receiptsFY2023$90.00MNew
Nov 9, 2022net decrease in cash and cash equivalents, short-term investments and restricted cashFY2022$105.00MLowered
Aug 11, 2022net decrease in cash, cash equivalents, and restricted cashFY2022$110.00MLowered
May 11, 2022net decrease in cash, cash equivalents, and restricted cashFY2022$120.00MReaffirmed
Mar 22, 2022capital expendituresFY2022$8.30MNew
Mar 22, 2022net decrease in cash, cash equivalents, and restricted cashFY2022$120.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Absci filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. News
  6. News
  7. Results
  8. Results
  9. Results
  10. Results
  11. Update
  12. News
  13. Results
  14. Results
  15. Results

See a number that looks wrong?